(Q43283685)

Dataset for "Continued use of retracted papers: Temporal trends in citations and (lack of) awareness of retractions shown in citation contexts in biomedicine"

18 November 2017

2 references

Continued use of retracted papers: Temporal trends in citations and (lack of) awareness of retractions shown in citation contexts in biomedicine

title

A role for plasma transforming growth factor-beta and matrix metalloproteinases in aortic aneurysm surveillance in Marfan syndrome? (English)

1 reference

18 November 2017

4

1 reference

18 November 2017

3

Ravi Savarirayan

1 reference

18 November 2017

Anna A Ahimastos

1

1 reference

18 November 2017

Anuradha Aggarwal

series ordinal

2

1 reference

18 November 2017

Bronwyn A Kingwell

series ordinal

5

1 reference

18 November 2017

publication date

8 August 2009

1 reference

18 November 2017

1 reference

18 November 2017

volume

209

1 reference

18 November 2017

issue

1

1 reference

18 November 2017

page(s)

211-214

1 reference

Effect of perindopril on large artery stiffness and aortic root diameter in patients with Marfan syndrome: a randomized controlled trial

18 November 2017

cites work

1 reference

30 December 2023

https://opencitations.net/index/api/v1/citations/10.1001/JAMA.298.13.1539

Dysregulation of TGF-beta activation contributes to pathogenesis in Marfan syndrome

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.ATHEROSCLEROSIS.2009.08.003

Recent advances in understanding Marfan syndrome: should we now treat surgical patients with losartan?

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.ATHEROSCLEROSIS.2009.08.003

Two-dimensional echocardiographic aortic root dimensions in normal children and adults

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.ATHEROSCLEROSIS.2009.08.003

Relation between age, arterial distensibility, and aortic dilatation in the Marfan syndrome.

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.ATHEROSCLEROSIS.2009.08.003

Doxycycline delays aneurysm rupture in a mouse model of Marfan syndrome

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.ATHEROSCLEROSIS.2009.08.003

Losartan, an AT1 antagonist, prevents aortic aneurysm in a mouse model of Marfan syndrome

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.ATHEROSCLEROSIS.2009.08.003

Latent transforming growth factor beta-binding protein 1 interacts with fibrillin and is a microfibril-associated protein

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.ATHEROSCLEROSIS.2009.08.003

Medical management of Marfan syndrome

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.ATHEROSCLEROSIS.2009.08.003

Extracellular control of TGFbeta signalling in vascular development and disease

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.ATHEROSCLEROSIS.2009.08.003

Basement membranes: structure, assembly and role in tumour angiogenesis

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.ATHEROSCLEROSIS.2009.08.003

The influence of angiotensin-converting enzyme inhibitors on the aorta elastin metabolism in diet-induced hypercholesterolaemia in rabbits

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.ATHEROSCLEROSIS.2009.08.003

Expression of matrix metalloproteinases and endogenous inhibitors within ascending aortic aneurysms of patients with Marfan syndrome

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.ATHEROSCLEROSIS.2009.08.003

Expansion of small-diameter abdominal aortic aneurysms is not reflected by the release of inflammatory mediators IL-6, MMP-9 and CRP in plasma

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.ATHEROSCLEROSIS.2009.08.003

Aneurysm syndromes caused by mutations in the TGF-beta receptor

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.ATHEROSCLEROSIS.2009.08.003

Reconsideration of echocardiographic standards for mitral valve prolapse: lack of association between leaflet displacement isolated to the apical four chamber view and independent echocardiographic evidence of abnormality

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.ATHEROSCLEROSIS.2009.08.003

Recent progress towards a molecular understanding of Marfan syndrome

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.ATHEROSCLEROSIS.2009.08.003

Evaluation of aortic insufficiency by Doppler color flow mapping

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.ATHEROSCLEROSIS.2009.08.003

Abnormal extracellular matrix protein transport associated with increased apoptosis of vascular smooth muscle cells in marfan syndrome and bicuspid aortic valve thoracic aortic aneurysm

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.ATHEROSCLEROSIS.2009.08.003

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.ATHEROSCLEROSIS.2009.08.003

Fibrillin-1 regulates the bioavailability of TGFbeta1.

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.ATHEROSCLEROSIS.2009.08.003

Identifiers

DOI

10.1016/J.ATHEROSCLEROSIS.2009.08.003

1 reference

18 November 2017

1 reference